Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved 17 March 2022 by the Certified Clinical Research Committee of Hiroshima University (certification number: CRB210005), registered with the Japan Registry of Clinical Trials (jRCTs062220008), and submitted by the Ministry of Health, Labour and Welfare.